Alyeska Investment Group’s Kalaris Therapeutics, Inc. Common Stock KLRS Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2023 Q3	–	Sell	-17,391	Closed	-$1.36M	–	622
2023 Q2	$1.36M	Buy	+17,391	New	+$1.36M	0.01%	405